ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,31
-0,27%
Bitcoin
67 729,13
-1,99%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) Actualités

ACAD Acadia Pharmaceuticals Inc

15,54
-0,28 (-1,77%)
Après les heures de négociation
Dernière mise à jour : 23:00:04
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,28 -1,77% 15,54 23:00:04
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
15,79 15,20 15,90 15,54 15,82
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
15/5/202415:05BWAcadia Pharmaceuticals Announces Launch of Magnolia's Guide..
09/5/202422:58BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
08/5/202422:10EDGAR2Form 8-K - Current report
08/5/202422:05BWAcadia Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202422:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
24/4/202422:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
22/4/202415:04BWAcadia Pharmaceuticals Announces Trofinetide New Drug..
19/4/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
17/4/202422:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
02/4/202422:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
01/4/202422:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
15/3/202421:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
13/3/202421:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
12/3/202412:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
11/3/202421:05EDGAR2Form 8-K - Current report
11/3/202421:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
29/2/202415:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
28/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:16EDGAR2Form 8-K - Current report
27/2/202422:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/2/202413:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202422:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
08/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/1/202403:55EDGAR2Form 8-K - Current report
31/1/202402:48BWAcadia Announces Additions to Executive Team
26/1/202423:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
18/1/202422:05BWAcadia Announces the Passing of Former President Srdjan..
10/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:05BWAcadia Pharmaceuticals to Present at the 42nd Annual J.P...
18/12/202322:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
16/12/202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202318:46EDGAR2Form 144 - Report of proposed sale of securities
14/12/202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
14/12/202303:24BWDelaware District Court Rules in Favor of Acadia on..
13/12/202319:41BWDelaware Federal District Court Rules in Favor of Acadia..
30/11/202315:05BWAcadia Pharmaceuticals Initiates Pivotal Phase 3 Study of..
28/11/202323:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202315:05BWAcadia Pharmaceuticals Initiates Phase 2 Clinical Trial of..
22/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ACAD
Acadia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés